Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients-Real-World Data From Hungary

• Main Authors: Szilvia Lovas (Author), Nóra Obajed Al-Ali (Author), Gergely Varga (Author), Virág Szita (Author), Hussain Alizadeh (Author), Márk Plander (Author), Péter Rajnics (Author), Árpád Illés (Author), Zsuzsa Szemlaky (Author), Gábor Mikala (Author), László Váróczy (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pomalidomide is a third generation immunomodulatory drug in the treatment of refractory and relapsed multiple myeloma patients. Our aim was to investigate the efficacy and safety of pomalidomide therapy in a real world setting. Eighty-six Hungarian patients were included, 45 of whom received pomalid...